Johns Hopkins Medicine and Walgreens WAG today announced they have entered into a wide-ranging agreement designed to promote collaboration on population-based research and to jointly review and develop protocols to improve outcomes of patients with chronic diseases. In addition, JHM and Walgreens will together explore the development of new models for improving care for individuals. This will include the creation of new educational and training programs for Walgreens 70,000 health care service providers.
The agreement provides JHM with the opportunity to develop innovative population-based research ideas with a nationwide industry leader who is committed to improving health care outcomes and possesses advanced data systems and a large patient base, prerequisites for such large-scale studies. As part of a commitment to patient privacy, all patient information used for these studies will be anonymous.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in